Skip to main content
Convatec Group PLC logo

Convatec Group PLC — Investor Relations & Filings

Ticker · CTEC ISIN · GB00BD3VFW73 LEI · 213800LS272L4FIDOH92 IL Manufacturing
Open in API
Filings indexed 480 across all filing types
Latest filing 2019-10-14 Director's Dealing
Country GB United Kingdom
Listing IL CTEC

About Convatec Group PLC

https://www.convatecgroup.com/

Convatec is a global medical products and technologies company focused on developing and marketing solutions for the management of chronic conditions. The company holds leading market positions in its four core franchises: Advanced Wound Care, which includes products for acute and chronic wounds; Ostomy Care, providing devices for people with stomas; Continence and Critical Care, offering solutions for bladder and bowel management; and Infusion Care, which supplies devices for subcutaneous drug delivery, primarily for insulin-dependent diabetes. Its products are designed to improve patient outcomes, prevent infection, protect at-risk skin, and reduce the total cost of care for healthcare providers and patients globally.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is an official notification filed via RNS (RNS Number : 8217P) dated October 14, 2019. The content explicitly details a 'Director/PDMR Shareholding' transaction involving the CEO, Karim Bitar, who sold shares to cover tax liabilities from an LTIP vesting. This type of insider transaction disclosure, specifically reporting personal share transactions by company directors and executives, directly matches the definition for 'Director's Dealing'. The code for this is DIRS.
2019-10-14 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document begins with an 'RNS Number' and is dated '04 October 2019'. The content explicitly details share transactions (grants and sales) by a Director/PDMR (the CEO, Karim Bitar) and includes a formal 'NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM'. This directly matches the definition of Director's Dealing (DIRS). Although it is distributed via RNS, the specific content is about insider trades, making DIRS the most precise classification over the general RNS fallback.
2019-10-04 English
Scrip Dividend - Total Issued Shares
Notice of Dividend Amount Classification · 1% confidence The document starts with an 'RNS Number' and is dated 27 September 2019. The content explicitly discusses the declaration of an interim dividend, the availability of a scrip dividend alternative, the number of new shares to be allotted and issued, and provides a detailed timetable for the dividend process. This directly relates to the announcement of dividend amounts and payment details. Therefore, the most specific classification is 'Notice of Dividend Amount' (DIV). Although it is distributed via RNS, DIV is more specific than the general RNS category.
2019-09-27 English
Acquisition
Regulatory Filings Classification · 1% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details an 'Acquisition of Southlake Medical Supplies,' which is a specific corporate action announcement. Since there is no specific category for M&A announcements that are short regulatory news items (TAR is for proposals/bids, but this is a definitive announcement), and given the format is a brief regulatory news service release, the most appropriate classification is the general regulatory filing category, RNS, as it is a standard regulatory news service announcement.
2019-09-18 English
Scrip Dividend - Calculation Price
Notice of Dividend Amount Classification · 1% confidence The document is identified by the RNS Number (1802M) and explicitly states it is being provided by RNS, the news service of the London Stock Exchange, which acts as a Primary Information Provider. The content details the calculation price and timetable for a Scrip Dividend related to a previously declared interim dividend. This is a specific announcement regarding a dividend action. The most fitting category among the provided definitions is 'Notice of Dividend Amount' (DIV), as it directly concerns the mechanics and pricing of a dividend payment, even though it is a scrip option. Since it is a formal regulatory announcement distributed via RNS, it could also be considered RNS, but DIV is more specific to the subject matter. Given the focus on the dividend calculation and timetable, DIV is the primary classification.
2019-09-12 English
John McAdam appointed Chairman of ConvaTec
Board/Management Information Classification · 1% confidence The document is an official announcement released via RNS (RNS Number : 4098J) from ConvaTec Group Plc, dated August 19, 2019. The core content announces the appointment of Dr. John McAdam as the new Chairman of the Board, effective September 30, 2019, and notes the stepping down of the interim Executive Chairman. This clearly falls under the category of announcing changes in the company's board of directors or senior management. This matches the definition for Board/Management Information (MANG). Although it is distributed via RNS, the specific content is about management change, making MANG the most precise classification.
2019-08-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.